Skip to main content
. 2022 Dec 16;14(24):5347. doi: 10.3390/nu14245347

Table 4.

Pharmacokinetics parameters of each curcuminoid when provided with a different formulation 1.

Curcuminoid Formulation 2 Tmax
(h)
p-Value 3 Cmax
(ng/mL)
p-Value C24 h
(ng/mL)
p-Value C1 h
(ng/mL)
p-Value AUC 0–24 h (ng/mL*h) p-Value AUC 0–6 h (ng/mL*h) p-Value
Curcumin MAG-OM3 4.2 ± 0.6 0.2502 12.9 ± 1.6 0.1152 2.3 ± 0.3 0.9675 8.6 ± 1.2 A <0.0001 134.3 ± 14.3 0.0307 39.3 ± 4.4 A 0.0337
Rice oil 5.1 ± 0.5 9.1 ± 0.9 2.1 ± 0.2 5.2 ± 0.7 A 110.1 ± 10.5 28.0 ± 3.3 B
Powder 5.8 ± 0.7 12.3 ± 1.3 2.2 ± 0.2 2.5 ± 0.6 B 132.0 ± 12.5 36.8 ± 4.1
Demethoxy-curcumin
(DMC)
MAG-OM3 2.3 ± 0.4 A 0.0009 3.3 ± 0.5 A 0.0102 0.2 ± 0.1 0.8440 2.8 ± 2.1 A <0.0001 22.6 ± 2.7 0.0576 8.9 ± 1.0 A 0.0113
Rice oil 3.5 ± 0.5 AB 2.0 ± 0.2 B 0.1 ± 0.1 1.5 ± 1.1 B 17.7 ± 1.8 6.1 ± 0.7 B
Powder 4.5 ± 0.4 B 2.5 ± 0.3 AB 0.2 ± 0.1 0.8 ± 1.0 B 22.2 ± 2.2 8.1 ± 0.9 AB
Bisdemethoxy-curcumin
(BDMC)
MAG-OM3 1.1 ± 0.1 A <0.0001 2.3 ± 0.3 A 0.0066 0.10 ± 0.03 0.8465 2.2 ± 1.6 A <0.0001 10.0 ± 1.0 0.1590 5.1 ± 0.5 A 0.0063
Rice oil 1.1 ± 0.1 A 1.6 ± 0.2 B 0.01 ± 0.06 1.6 ± 1.1 B 7.1 ± 0.8 3.5 ± 0.4 B
Powder 1.8 ± 0.2 B 1.5 ± 0.1 B 0.05 ± 0.04 0.8 ± 0.9 B 9.3 ± 0.8 4.6 ± 0.4 AB
Total Curcuminoids MAG-OM3 3.4 ± 0.5 0.1681 17.7 ± 2.3 0.0939 2.5 ± 0.4 0.7283 13.6 ± 1.8 A <0.0001 166.8± 17.8 A 0.0297 53.3 ± 5.9 A 0.0230
Rice oil 4.3 ± 0.5 11.9 ± 1.1 2.2 ± 0.3 8.2 ± 1.0 B 134.0 ± 12.7 B 37.6 ± 4.3 B
Powder 4.8 ± 0.4 15.7 ± 1.6 2.4 ± 0.3 4.1 ± 0.9 C 163.1 ± 15.3 AB 49.5 ± 5.4 AB

1 Results are mean ± SEM. 2 All formulations contain 400 mg of curcuminoid extract, MAG-OM3 = Omega-3 esterified in monoglycerides. 3 Data were not normally distributed, and a Friedman non-parametric test was used and if it met statistical difference to compare each formulation a Dunn’s multiple comparisons was used and statistical difference was represented by different letters.